Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000263457

Medchemexpress LLC 5-(5-bromo-2-((2-bromobenzyl)oxy)benzylidene)-2-thioxothiazolidin-4-one | 893449-38-2 | MFCD11045303 | 99.1% | 485.21 | C17H11Br2NO2S2 | 5 MG
SDP

Catalog No. 5000263457
Encompass_Preferred

PRL-3 Inhibitor I is a small-molecule research reagent that inhibits the phosphatase PRL-3 (PTP4A3) and is used to probe PRL-3-dependent signaling and cellular invasion. The compound is provided as a high-purity solid; DMSO is the recommended solvent for preparing assay stock solutions.

  • Potent PRL-3 inhibition with IC50 0.9 μM.
  • High purity suitable for biochemical and cell-based assays.
  • Molecular formula C17H11Br2NO2S2; molecular weight 485.21.
  • Available in small milligram quantities and as DMSO stock solutions for convenient assay setup.
  • Supplied for research use only; not for human or clinical use.

Catalog No. 50-002-63457 Supplier Medchemexpress LLC Supplier No. HY1124765MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PRL-3 Inhibitor I is a small-molecule research reagent that inhibits the phosphatase PRL-3 (PTP4A3) and is used to probe PRL-3-dependent signaling and cellular invasion. The compound is provided as a high-purity solid; DMSO is the recommended solvent for preparing assay stock solutions.

  • Potent PRL-3 inhibition with IC50 0.9 μM.
  • High purity suitable for biochemical and cell-based assays.
  • Molecular formula C17H11Br2NO2S2; molecular weight 485.21.
  • Available in small milligram quantities and as DMSO stock solutions for convenient assay setup.
  • Supplied for research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.